In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
75 News Items found
Pouring white wine into a glass
Feature
White Wine and Melanoma: Does Drinking Alcohol Increase Your Cancer Risk?

Hear from our experts about a new study linking alcohol consumption and melanoma risk.
Dr. Robin Mendelsohn
MSK Expert Weighs in On New Colorectal Cancer Screening Recommendations

The United States Preventive Services Task Force released updated draft recommendations on colorectal cancer screening which, among other things, call for screening for the general population to begin at age 45.
Dr. Zsofia Stadler
Finding
Preventing Lynch Syndrome Cancers: New Study Suggests Immunotherapy Could Work

An analysis of patients with Lynch syndrome treated at MSK finds that immunotherapy drugs called checkpoint inhibitors may prevent serious tumors from forming.
Emmanouil Pappou
Don’t Skip Routine Cancer Screenings: MSK Patient Shares How a Colonoscopy May Have Saved Her Life

Dr. Emmanouil Pappou urges the importance of routine cancer screenings, even during COVID-19, on the TODAY Show.
Amy Speck
Top Cancer Treatment Advances at MSK in 2024

Learn about some of the most important advances in cancer treatment and clinical trials at MSK in 2024.
Antonio Lekhrajmal is seen outdoors with his wife, Maria. He has been successfully treated with checkpoint inhibitors for advanced stomach cancer.
How Checkpoint Inhibitors for Stage 4 Stomach Cancer Worked for Antonio

Learn how MSK helped a man with stage 4 stomach (gastric) cancer using checkpoint inhibitors, a type of immunotherapy that also treats many other cancers.
A female nurse talks with a female patient, who is sitting in an exam chair
Feature
A Decade of Progress in Cancer Care, and What’s Next

Advances in diagnosis and treatment, especially those made over the past ten years, have played a significant role in the decline in cancer deaths. Learn about those advances — and what to expect in the next ten years.
Memorial Sloan Kettering neuro-oncologist Adrienne Boire
Roundup
Year in Review: Five Important Clinical Advances in Cancer in 2020

Read about some of the most important clinical advances made at MSK in 2020.
scale
Q&A
Why Are More Young Adults Getting Cancer? Obesity May Be to Blame

Cancer among younger Americans is on the rise, and much of it is linked to obesity. An MSK expert on diet and cancer explains what’s behind this disturbing new trend.
Piro Lito, Bob Li, and Neal Rosen in the lab
In the Clinic
Promising Results from the First-Ever Trial of a Drug that Blocks Cancer Gene KRAS

The drug, sotorasib, is targeted against a cancer-causing protein that has long been considered an “undruggable” target.